{
	"symbol": "EPRX",
	"name": "Eupraxia Pharmaceuticals Inc.",
	"price": 4.91,
	"priceChange": 0.18,
	"percentChange": 3.805497,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 16571,
	"openPrice": 4.72,
	"dayHigh": 4.91,
	"dayLow": 4.7,
	"MarketCap": 174906736,
	"MarketCapAllClasses": 174906736,
	"peRatio": "",
	"prevClose": 4.73,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 1.228046,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations.",
	"fulldescription": "Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations.",
	"website": "http://www.eupraxiapharma.com",
	"email": "",
	"phoneNumber": "+1 250 590-3968",
	"fullAddress": "204 - 2590 Cadboro Bay Road, Victoria, BC, CA",
	"employees": "29",
	"shareOutStanding": 35622553,
	"totalDebtToEquity": 0.31,
	"totalSharesOutStanding": 35622553,
	"sharesESCROW": null,
	"vwap": 4.77262195,
	"dividendPayDate": null,
	"weeks52high": 7.64,
	"weeks52low": 3.07,
	"alpha": 0.002012,
	"averageVolume10D": 39341,
	"averageVolume20D": 60591,
	"averageVolume30D": 48522,
	"averageVolume50D": 34552,
	"priceToBook": 8.72,
	"priceToCashFlow": -4.2,
	"returnOnEquity": -246.81,
	"returnOnAssets": -99.1,
	"day21MovingAvg": 4.184762,
	"day50MovingAvg": 3.7922,
	"day200MovingAvg": 4.0824,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 4.91,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}